ADAGE CAPITAL PARTNERS GP, L.L.C. - 31 Dec 2024 SCHEDULE 13G/A Report for Syros Pharmaceuticals, Inc. Common stock, par value $0.001 per share (SYRS)

Filing Manager: ADAGE CAPITAL PARTNERS GP, L.L.C.
Reporting Manager: Adage Capital Management, L.P.
Security: Syros Pharmaceuticals, Inc. Common stock, par value $0.001 per share
Symbol: SYRS
Shares outstanding: 26,864,343 shares
Disclosed Ownership: 531,914 shares
Ownership: 1.98%
Form type: SCHEDULE 13G/A
Filing time: 12 Feb 2025, 09:41:28 UTC
Date of event: 31 Dec 2024
SEC: View on sec.gov

Reporting Managers (4)

Name	Ownership	Shares Owned	shared voting power	Signature	Title
Adage Capital Management, L.P.	1.98%	531,914	531,914	/s/ Robert Atchinson	By: Adage Capital Partners LLC, its General Partner, By: Robert Atchinson, its Managing Member
Adage Capital Partners GP, L.L.C.	0%	0	0	s/ Robert Atchinson	By: Adage Capital Advisors, L.L.C., its Managing Member, By: Robert Atchinson, its Managing Member
Robert Atchinson	1.98%	531,914	531,914	s/ Robert Atchinson	Robert Atchinson, individually
Phillip Gross	1.98%	531,914	531,914	s/ Phillip Gross	Phillip Gross, individually